The standardized mortality rate from malignant neoplasms for men in Finland is projected to decline from 216.8 deaths per 100,000 men in 2024 to 208.0 deaths by 2028. This marks a consistent downward trend. Specifically, the year-on-year decrease from 2024 to 2025 is 1.1%, from 2025 to 2026 is 1.0%, from 2026 to 2027 is 1.0%, and from 2027 to 2028 is 1.0%. The compound annual growth rate (CAGR) over these five years averages at approximately -1.0% per year, highlighting a steady reduction in mortality rates.
Future trends to watch for include advancements in cancer treatments, early detection technologies, and effective public health campaigns, which could further accelerate the decline in malignancy-related mortality rates. Additionally, socioeconomic factors, healthcare access, and lifestyle changes could play significant roles in shaping these trends.
